The meal is pushed way, untouched. Loss of appetite can be a fleeting queasiness or continue to the point of emaciation. While it's felt in the gut, more is going on inside the head. New findings are emerging about brain and body messaging pathways that lead to loss of appetite, and the systems in place to avoid starvation.
Today, scientists report in Nature about a brain circuit that mediates the loss of appetite in mice. The researchers also discovered potential therapeutic targets within the pathway. Their experimental results may be valuable for developing new treatments for a variety of eating disorders. These include unrelenting nausea, food aversions, and anorexia nervosa, a condition in which a person no longer wants to eat enough to maintain a normal weight.
The senior author of the paper is Dr. Richard D. Palmiter, University of Washington professor of biochemistry and an investigator with the Howard Hughes Medical Institute. His co-authors are Dr. Qi Wu, formerly of the UW and now at the Eagles Diabetes Research Center and Department of Pharmacology at Carver College of Medicine, University of Iowa, and Dr. Michael S. Clark of the UW Department of Psychiatry and Behavioral Sciences. Palmiter is known for co-developing the first transgenic mice in the 1980s with Dr. Ralph Brinster at the University of Pennsylvania. His more recent studies are of chemicals that nerve cells use to communicate with each other, their roles in mouse brain development and function, and their relation to behavior.
Palmiter and his colleagues concentrated on a part of the brain, a relay center called the parabrachial nucleus, because it is an important hub for integrating signals from several brain regions to modulate food intake. Nausea, as well as taste aversion or preferences, may originate from signals processed in the parabrachial nucleus.
In this most recent study, the researchers discovered the type and location of brain cells that send signals that agitate the parabrachial nucleus and thereby squelch the ability to eat. They also demonstrate how these signals can be blocked to restore normal appetite and to ward off starvation.
Earlier studies by Palmiter's team and by Dr. Michael Schwartz' team at the UW Center for Excellence in Diabetes and Obesity Research showed that certain nerve cells in the brain's hypothalamus play a role in promoting feeding and weight gain. They do so by collating a variety of signals from the body. If these brain cells are destroyed, feeding stops. Meals will be refused and liquid food placed into the mouth will hardly be swallowed.
The researchers later learned that the ensuing starvation is due to the excessive activation of the brain's parabrachial nucleus. The researchers found that starvation could be prevented by improving receptor signaling for a substance called GABA and thereby calm the excited parabrachial nucleus. This intervention had to be done within a critical adaptation period to be successful. GABA is one of the most common neurotransmitters – chemicals that ferry messages to and from nerve cells in the brain.
At first, the scientists were puzzled about the source of the command that turns on the parabrachial nucleus and makes it turn feeding off. Their research fingered two suspects and their locations in the brain. Their studies pointed out nerve cells involved with another neurotransmitter, glutamate, in the part of the brain called the nucleus tractus solitarus. Also contributing to the abnormal activation were cells involved in serotonin signaling. Both drive the hyper-excitability of nerve cells in the parabrachial nucleus that inhibit feeding.
The researchers went on to discover several ways to reinstate normal appetite by interfering with input signaling from these two cell types. They also tested how to censor "don't eat" signals coming from cells in the parabrachial nucleus.
Their studies revealed six interventions that prevented starvation when the cells that modulate food intake in the hypothalamus no longer function. These interventions acted upon various aspects of signaling to and from the parabrachial nucleus, in most cases by disabling or reducing signals or their receptors.
The researchers were able to prevent severe loss of appetite in their mouse model by administering bretazenil, a drug that promotes GABA signaling, or by administering ondansetron, a drug used to prevent nausea and vomiting during cancer chemotherapy. The Palmiter team also used specially constructed viruses to selectively reduce signaling by glutamate – the major excitatory signal in the brain.
The researchers believe that additional progress in dissecting circuits that control feeding will be achieved by identifying genes that are active in specific populations of brain cells within the parabrachial nucleus. Finding such genes will allow investigators to selectively manipulate their activity in the mouse and thereby control feeding behaviors.
This study was supported in part by a grant from the National Institutes of Health's National Institute on Drug Abuse.
Leila Gray | EurekAlert!
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy